Literature DB >> 11260315

Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

M Vukmanovic-Stejic1, M J Thomas, A Noble, D M Kemeny.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11260315      PMCID： PMC1783169          DOI： 10.1046/j.1365-2567.2001.01193.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  97 in total

1.  Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction.

Authors:  U Shu; M Kiniwa; C Y Wu; C Maliszewski; N Vezzio; J Hakimi; M Gately; G Delespesse
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

2.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

Authors:  S Sad; R Marcotte; T R Mosmann
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

3.  Human CD8+ T lymphocyte clones specific for T cell receptor V beta families expressed on autologous CD4+ T cells.

Authors:  R Ware; H Jiang; N Braunstein; J Kent; E Wiener; B Pernis; L Chess
Journal:  Immunity       Date:  1995-02       Impact factor: 31.745

4.  Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.

Authors:  Y Chen; J Inobe; H L Weiner
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

5.  Cytokine production by highly purified human CD8+ T cells.

Authors:  Y Li; D Richards; A Noble; D M Kemeny
Journal:  Int Arch Allergy Immunol       Date:  1995 May-Jun       Impact factor: 2.749

6.  Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule.

Authors:  H Jiang; R Ware; A Stall; L Flaherty; L Chess; B Pernis
Journal:  Immunity       Date:  1995-02       Impact factor: 31.745

7.  In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.

Authors:  S Y Chan; L A DeBruyne; R E Goodman; E J Eichwald; D K Bishop
Journal:  Transplantation       Date:  1995-04-27       Impact factor: 4.939

8.  Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.

Authors:  V Rus; A Svetic; P Nguyen; W C Gause; C S Via
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

Review 9.  Eosinophil adhesion in allergic inflammation.

Authors:  A J Wardlaw; F S Symon; G M Walsh
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

10.  Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia.

Authors:  A J Coyle; F Erard; C Bertrand; S Walti; H Pircher; G Le Gros
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307
View more
  5 in total

1.  Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation.

Authors:  Axel Trautmann; Beate Rückert; Peter Schmid-Grendelmeier; Eva Niederer; Eva-B Bröcker; Kurt Blaser; Cezmi A Akdis
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

Review 2.  The role of regulatory T cells in allergy.

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Springer Semin Immunopathol       Date:  2003-10-22

3.  Identity of activation molecule 3 on superantigen-stimulated bovine cells is CD26.

Authors:  S U Lee; W Ferens; W C Davis; M J Hamilton; Y H Park; L K Fox; J Naessens; G A Bohach
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Colitis immunoregulation by CD8+ T cell requires T cell cytotoxicity and B cell peptide antigen presentation.

Authors:  Michael McPherson; Bo Wei; Olga Turovskaya; Daisuke Fujiwara; Sarah Brewer; Jonathan Braun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-10       Impact factor: 4.052

Review 5.  Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?

Authors:  Muhammad Sadeqi Nezhad; Alexander Seifalian; Nader Bagheri; Sajad Yaghoubi; Mohammad Hossein Karimi; Meghdad Adbollahpour-Alitappeh
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.